Parent-dependent barriers to varicella immunization in Israel: The importance of adequate information

Acta Paediatrica, International Journal of Paediatrics

Volumn 96, Issue 3, 2007, Pages 428-431

  Adler, Amos ^a,b,d   Herring, Eli ^c   Babilsky, Hanan ^c   Gazala, Eli ^c   Cohen, Avner ^c   Levy, Itzhak ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c General Health Services   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Barriers to vaccination; Parental education; Varicella

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; CHICKENPOX; CHILD; EDUCATIONAL STATUS; HUMAN; IMMUNIZATION; INFORMATION PROCESSING; ISRAEL; OUTPATIENT DEPARTMENT; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIOECONOMICS; TIME SERIES ANALYSIS; VACCINATION; VARICELLA ZOSTER VIRUS;

ADOLESCENT; ADULT; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; ISRAEL; MALE; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; SOCIAL CLASS; VACCINATION;

EID: 33947321747     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2007.00118.x     Document Type: Article

References (24)

1. CDC. Prevention of varicella recommendation of the Advisory Committee on Immunization Practice (ACIP). MMWR 1996; 45: 1-36.
2. Somekh E, Maharshak N, Shapira Y, Greenberg D, Dagan R. Hospitalization for primary varicella-zoster virus infection and its complications in patients from southern Israel. Infection 2000; 28: 200-4.
3. Maharshak N, Somekh E. Hospitalization for varicella in central Israel. Acta Paediatr 1999; 88: 1279-83.
4. Somekh E, Dalal I, Shohat T, Ginsberg GM, Romano O. The burden of uncomplicated chickenpox in Israel. J Infect 2002; 45: 54-7.
5. Sheffer R, Segal D, Rahamani S, Dalal I, Linhart Y, Stein M, et al. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel. Pediatr Infect Dis J 2005; 24: 434-7.
6. Miron D, Lavi I, Kitov R, Hendler A. Vaccine effectiveness and severity of varicella among previously vaccinated children during outbreaks in day-care centers with low vaccination coverage. Pediatr Infect Dis J 2005; 24: 233-6.
7. Pezzino G, Voss SC. Varicella-related deaths - United States, 2002. MMWR 2003; 52: 545-6.
8. Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Modelling the impact of immunisation on the epidemiology of varicella zoster virus. Epidemiol Infect 2000; 125: 651-69.
9. Ehersmann KR, Mills WA, Loewenson PR, Moore KA. Attitudes and practices regarding varicella vaccination among physicians in Minnesota: implication for public health and provider education. Am J Public Health 2000; 90: 1917-20.
10. Newman RD, Taylor JA. Reactions of pediatricians to the recommendation for universal varicella vaccination. Arch Pediatr Adolesc Med 1998; 152: 792-6.
11. Katz-Sidlow RJ, Sidlow R. A look at the pediatrician as a parent: experiences with the introduction of varicella vaccine. Clin Pediatr 2003; 42: 635-40.
12. Milledge JT, Cooper CD, Woolfenden SR. Barriers to immunization: attitudes of general practitioners to varicella, the disease and its vaccine. J Pediatr Child Health 2003; 39: 368-71.
13. Gustafson R, Skowronski DM. Disparities in varicella vaccine coverage in the absence of public funding. Vaccine 2005; 23: 3519-25.
14. Taylor JA, Newman RD. Parental attitude toward varicella vaccination. Arch Pediatr Adolesc Med 2000; 154: 302-6.
15. De Serres G, Duval B, Boulianne N. Impact of vaccine cost and information about complications of varicella on parental decision regarding varicella vaccine. Can J Public Health 2002; 93: 114-6.
16. Israeli Central Bureau of Statistics. The 1995 Population Census: Local Authorities-Rank, Cluster Membership, Population. Available at: http://www1.cbs.gov.il/mifkad/tables/pirsom13/1.xls. Accessed August 2, 2005.
17. Savas S, Dallar Y, Arikan I, Onde U. Varicella-zoster virus seroprevalence in children between 0-15 years old. Mikrobiyol Bul 2004; 38: 69-75.
18. Heininger U, Braun-Fahrländer C, Desgrandchamps D, Glaus J, Grize L, Wutzler P, et al. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity. Pediatr Infect Dis J 2001; 20: 775-8.
19. Salleras L, Dominguez À , Vidal J, Plans P, Salleras M, Taberner JL. Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programs. Vaccine 2001; 19: 183-8.
20. Passwell JH, Hemo B, Levi Y, Rmon R, Friedman N, Lerner-Geva L. Use of a computerized database to study the effectiveness of an attenuated varicella vaccine. Pediatr Infect Dis J 2004; 23: 221-6.
21. Bates AS, Wolinsky FD. Personal, financial, and structural barriers to immunization in socioeconomic disadvantaged urban children. Pediatrics 1998; 101: 591-6.
22. Stokley S, Smith PJ, Klevens RM, Battaglia MP. Vaccination status in children living in rural areas in the United States. Am J Prev Med 2001; 20: 55-60.
23. Hughart N, Strobino D, Holt E, Guyer B, Hon W, Huq A, et al. Relation of parent and provider characteristics to vaccination status of children in private practices and managed care organizations in Maryland. Med Care 1999; 37: 44-55.
24. Taylor JA, Darden PM, Brooks DA, Hendricks JW, Wasserman RC, Bocian AB. Association between parents' preferences and perceptions of barriers to vaccination and the immunization status of their children: a study from Pediatric Research in Office Settings and the National Medical Association. Pediatrics 2002; 110: 1110-6.